Top Growth Trends in the Kernicterus Treatment Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the Kernicterus Treatment market grown in recent years?
The market size of kernicterus treatment has been experiencing a consistent growth in the past few years. It’s forecasted to rise from $2.98 billion in 2024 to $3.06 billion in 2025, growing at a compound annual growth rate (CAGR) of 3.0%. Factors contributing to the growth during the historic period include enhancements in neonatal care practices, heightened awareness among medical healthcare professionals, governmental measures promoting maternal and child health, funding for research and clinical trials, and collaborations in the field of medical research.
How is the kernicterus treatment market size expected to evolve during the forecast period?
In the coming years, the market size for kernicterus treatment is predicted to experience consistent growth, reaching $3.37 billion in 2029 with a 2.4% compound annual growth rate (CAGR). This predicted growth during the forecast period is due to factors such as continuous medical education programs, global health strategies, patient advocacy and supporting groups, contributions in pediatric research at an international level, and neonatal health government funding. During the forecast period, the primary trends to watch for are advancements in neonatal jaundice monitoring technologies, the launch of phototherapy devices featuring improvements, the formulation of medications minimizing bilirubin, focus on phototherapy solutions based at home, the implementation of bilirubin nomograms and guidelines, and the integration of telehealth for monitoring remotely.
Get your kernicterus treatment market report here!
https://www.thebusinessresearchcompany.com/report/kernicterus-treatment-global-market-report
Which key drivers are propelling the kernicterus treatment market’s growth?
The upward trend of neonatal jaundice incidence drives the increasing demand for kernicterus treatment, a major factor contributing to market growth. Neonatal jaundice, displaying through newborns’ yellow skin and eye whites, is a typical benign condition. Kernicterus treatment, a standard procedure for neonatal jaundice, effectively manages the condition’s symptoms and enhances supportive care. The therapy reduces the blood’s bilirubin level, remarkably improving the child’s life quality. For instance, the National Library of Medicine, a US-based biomedical library, noted in their October 2023 reports that approximately 60% of fully developed babies and 80% of premature babies develop jaundice during their initial life week. Moreover, about 10% of babies who are breastfed remain jaundiced at one month old. The enlarging neonatal jaundice occurrence is expected to fuel the kernicterus treatment market’s growth.
Kernicterus Treatment Market Driver: Surge in Healthcare Investments Encouraging Treatment Approach
What are the market segments in the kernicterus treatment industry?
The kernicterus treatment market covered in this report is segmented –
1) By Treatment: Phototherapy, Intravenous Immunoglobulins (IVIG), Blood Transfusion, Medication, Other Treatments
2) By Symptoms: Jaundice, Unusual Eye Movements, Vomiting, Fever, Poor Feeding, Apnoea, Irritability, Seizures, Sleepiness, Other Symptoms
3) By Dosage: Injection, Solution, Other Dosages
4) By End-Users: Clinic, Hospital, Other End-Users
Subsegments:
1) By Phototherapy: Conventional Phototherapy, Fiberoptic Phototherapy, LED Phototherapy
2) By Intravenous Immunoglobulins (IVIG): Standard IVIG Therapy, High-Dose IVIG Therapy
3) By Blood Transfusion: Exchange Transfusion, Simple Transfusion
4) By Medication: Bilirubin-Lowering Agents, Antioxidants, Neuroprotective Agents
5) By Other Treatments: Supportive Care, Nutritional Support, Adjunct Therapies
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13470&type=smp
Which leading companies are shaping the growth of the kernicterus treatment market?
Major companies operating in the kernicterus treatment market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca plc., Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Johnson and Johnson Private Limited, Baxter International Inc., Grifols S.A, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Alembic Pharmaceuticals Limited, Lupin Pharmaceuticals Inc., CSL Limited, Glenmark Pharmaceuticals Ltd., Cipla Inc., Torrent Pharmaceuticals Ltd., Octapharma Brasil Ltda, Kedrion S.p.A, Biotest AG, Wockhardt Ltd., Mylan N.V., Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., China Biologic Products Holdings Inc.
What key trends are currently impacting the kernicterus treatment market’s development?
Primary establishments engaged in the cornea treatment market are honing their strategies towards partnerships with a view to expand their reach and achieve a competitive edge. For example, in July 2024, the UCL Department of Medical Physics and Biomedical Engineering, a UK-based institution focused on research and education in medical physics and biomedical engineering, joined forces with UCL Hospitals. Together, they introduced NeoSCB, a smartphone application designed to diagnose severe jaundice in neonates. The app works by processing images of the sclera (the white area of the eye) to provide an unobtrusive screening method. This approach is particularly useful in areas with limited resources where the typical jaundice screening equipment tends to be expensive. By determining the degree of yellowness of the sclera, the app aligns this data with the bilirubin levels in the blood. The application has proved to be highly accurate, accurately identifying 74 out of 79 severely jaundiced infants which is on par with traditional methods such as transcutaneous bilirubinometers that estimate bilirubin levels through the skin.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13470
Which geographic areas are influencing the growth of the kernicterus treatment market?
North America was the largest region in the kernicterus treatment market in 2024. The regions covered in the kernicterus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024
Hypertrophic Cardiomyopathy Treatment Global Market Report 2024
Neurofibromatosis Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
